Transplantation, ISSN 0041-1337, 08/2017, Volume 101, Issue 8, pp. e282 - e283
Journal Article
Transplantation, ISSN 0041-1337, 08/2017, Volume 101, Issue 8, pp. e282 - e283
Journal Article
Transplantation, ISSN 0041-1337, 05/2017
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2015, Volume 13, Issue 7, pp. 1361 - 1363
Gastroenterology and Hepatology | UNITED-STATES | MORTALITY | SURVIVAL | DISEASE | LIVER INTENSIVE-CARE | GASTROENTEROLOGY & HEPATOLOGY | BURDEN | Severity of Illness Index | Liver Failure - mortality | Fibrosis - complications | Humans | Decision Support Techniques | Critical Care | Female | Male | Fibrosis - mortality | Liver Failure - diagnosis | Liver cirrhosis | Care and treatment | Patient outcomes
Journal Article
Critical Care Medicine, ISSN 0090-3493, 09/2019, Volume 1, Issue 9, p. e0040
Journal Article
Journal of Hepatology, ISSN 0168-8278, 07/2018, Volume 69, Issue 1, p. 248
A hepatology snapshot of for drug-induced chronic liver injury is presented. The pathology of drug-induced liver injury by causative agents is outlined. These...
Drugs | Liver diseases | Hepatology | Liver | Bile duct
Drugs | Liver diseases | Hepatology | Liver | Bile duct
Journal Article
Current Hepatology Reports, 9/2018, Volume 17, Issue 3, pp. 254 - 259
Idiosyncratic drug-induced liver injury (DILI) typically presents acutely with liver test abnormalities, sometimes with associated symptoms of abdominal pain,...
Nodular regenerative hyperplasia | Sinusoidal obstruction syndrome | Drug-induced liver injury | Medicine & Public Health | Hepatology | Atypical manifestations
Nodular regenerative hyperplasia | Sinusoidal obstruction syndrome | Drug-induced liver injury | Medicine & Public Health | Hepatology | Atypical manifestations
Journal Article
Liver Transplantation, ISSN 1527-6465, 11/2019, Volume 25, Issue 11, pp. 1634 - 1641
Racial and ethnic differences in the presentation and outcomes of patients wait‐listed with acute liver failure (ALF) have not been explored. Adult patients...
Journal Article
Chest, ISSN 0012-3692, 02/2019, Volume 155, Issue 2, pp. 307 - 314
Treatment of hepatic hydrothorax (HH) generally involves sodium restriction, diuretics, and serial thoracentesis. In more advanced cases, transjugular...
empyema | hepatic hydrothorax | liver transplant | indwelling pleural catheter
empyema | hepatic hydrothorax | liver transplant | indwelling pleural catheter
Journal Article
10.
Full Text
Incidence, risk factors and outcomes of de novo malignancies post liver transplantation
世界肝病学杂志:英文版(电子版), ISSN 1948-5182, 2016, Volume 8, Issue 12, pp. 533 - 544
Liver transplantation(LT) is associated with a 2 to7 fold higher, age and gender adjusted, risk of de novo malignancy. The overall incidence of de novo...
transplant;Immunosuppression;Risk;Outcomes;Malignancy | Liver | Liver transplant | Risk | Immunosuppression | Malignancy | Outcomes | Topic Highlight
transplant;Immunosuppression;Risk;Outcomes;Malignancy | Liver | Liver transplant | Risk | Immunosuppression | Malignancy | Outcomes | Topic Highlight
Journal Article
Transplantation, 08/2017, Volume 101, Issue 8, p. e282
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 08/2019, Volume 50, Issue 3, pp. 317 - 328
Summary Background Metformin may protect against hepatocellular carcinoma and mortality among patients with type 2 diabetes. Aim To investigate whether...
MORTALITY | HEPATOCELLULAR-CARCINOMA | VITAMIN-E | IMPACT | LUNG-CANCER PATIENTS | METAANALYSIS | MANAGEMENT | PROGNOSIS | FATTY LIVER-DISEASE | RISK | PHARMACOLOGY & PHARMACY | GASTROENTEROLOGY & HEPATOLOGY | Type 2 diabetes | Diabetics | Medical research | Care and treatment | Usage | Patient outcomes | Liver | Mortality | Development and progression | Fibrosis | Medicine, Experimental | Metformin | Liver cirrhosis | Diabetes mellitus | Hepatocellular carcinoma | Survival | Patients | Liver cancer | Cirrhosis | Medical centres | Biopsy | Diabetes | Acidosis | Hepatotoxicity | Diabetes mellitus (non-insulin dependent) | Lactic acidosis | Index Medicus
MORTALITY | HEPATOCELLULAR-CARCINOMA | VITAMIN-E | IMPACT | LUNG-CANCER PATIENTS | METAANALYSIS | MANAGEMENT | PROGNOSIS | FATTY LIVER-DISEASE | RISK | PHARMACOLOGY & PHARMACY | GASTROENTEROLOGY & HEPATOLOGY | Type 2 diabetes | Diabetics | Medical research | Care and treatment | Usage | Patient outcomes | Liver | Mortality | Development and progression | Fibrosis | Medicine, Experimental | Metformin | Liver cirrhosis | Diabetes mellitus | Hepatocellular carcinoma | Survival | Patients | Liver cancer | Cirrhosis | Medical centres | Biopsy | Diabetes | Acidosis | Hepatotoxicity | Diabetes mellitus (non-insulin dependent) | Lactic acidosis | Index Medicus
Journal Article
Chest, ISSN 0012-3692, 02/2019, Volume 155, Issue 2, pp. 307 - 314
Background: Treatment of hepatic hydrothorax (HH) generally involves sodium restriction, diuretics, and serial thoracentesis. In more advanced cases,...
empyema | hepatic hydrothorax | liver transplant | indwelling pleural catheter | INFECTIONS | MANAGEMENT | TRANSPLANT | CHEST | RESPIRATORY SYSTEM | INTRAHEPATIC PORTOSYSTEMIC SHUNT | EFFUSIONS | CIRRHOTIC-PATIENTS | CRITICAL CARE MEDICINE | Care and treatment | Usage | Hydrothorax | Liver | Transplantation | Diagnosis | Risk factors
empyema | hepatic hydrothorax | liver transplant | indwelling pleural catheter | INFECTIONS | MANAGEMENT | TRANSPLANT | CHEST | RESPIRATORY SYSTEM | INTRAHEPATIC PORTOSYSTEMIC SHUNT | EFFUSIONS | CIRRHOTIC-PATIENTS | CRITICAL CARE MEDICINE | Care and treatment | Usage | Hydrothorax | Liver | Transplantation | Diagnosis | Risk factors
Journal Article
Transplantation, 05/2017
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 2009, Volume 104, Issue 4, pp. 828 - 833
OBJECTIVES: The etiology of eosinophilic esophagitis (EoE) is not well understood. It has been proposed that eosinophils migrate to the esophagus in response...
GASTROESOPHAGEAL-REFLUX | SERIES | PATCH TESTS | HISTOLOGIC-FINDINGS | POLLEN | SKIN PRICK | GASTROENTEROLOGY & HEPATOLOGY | CHILDREN | FOOD | United States - epidemiology | Prevalence | Humans | Middle Aged | Male | Eosinophilia - epidemiology | Esophagitis - pathology | Eosinophilia - pathology | Esophagitis - epidemiology | Female | Endoscopy, Gastrointestinal - methods | Retrospective Studies | Seasons
GASTROESOPHAGEAL-REFLUX | SERIES | PATCH TESTS | HISTOLOGIC-FINDINGS | POLLEN | SKIN PRICK | GASTROENTEROLOGY & HEPATOLOGY | CHILDREN | FOOD | United States - epidemiology | Prevalence | Humans | Middle Aged | Male | Eosinophilia - epidemiology | Esophagitis - pathology | Eosinophilia - pathology | Esophagitis - epidemiology | Female | Endoscopy, Gastrointestinal - methods | Retrospective Studies | Seasons
Journal Article
Hepatology, ISSN 0270-9139, 04/2017, Volume 65, Issue 4, pp. 1267 - 1277
Bile duct loss during the course of drug‐induced liver injury is uncommon, but can be an indication of vanishing bile duct syndrome (VBDS). In this work, we...
ACID | INTRAHEPATIC CHOLESTASIS | PROLONGED CHOLESTASIS | GASTROENTEROLOGY & HEPATOLOGY | INDUCED LIVER-INJURY | FEATURES | TEMOZOLOMIDE | DUCTOPENIA | Immunohistochemistry | Prognosis | Age Factors | United States | Humans | Middle Aged | Male | Bile Duct Diseases - chemically induced | Bile Duct Diseases - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Incidence | Statistics, Nonparametric | Aged, 80 and over | Adult | Female | Retrospective Studies | Dietary Supplements - adverse effects | Chemical and Drug Induced Liver Injury - pathology | Pharmaceutical Preparations - administration & dosage | Databases, Factual | Bile Ducts - drug effects | Risk Assessment | Chemical and Drug Induced Liver Injury - epidemiology | Drug-Related Side Effects and Adverse Reactions - etiology | Chi-Square Distribution | Drug-Related Side Effects and Adverse Reactions - epidemiology | Sex Factors | Aged | Biopsy, Needle | Bile Duct Diseases - pathology | Bile Ducts - pathology | Cohort Studies | Liver | Rodents | Dietary supplements | Bile
ACID | INTRAHEPATIC CHOLESTASIS | PROLONGED CHOLESTASIS | GASTROENTEROLOGY & HEPATOLOGY | INDUCED LIVER-INJURY | FEATURES | TEMOZOLOMIDE | DUCTOPENIA | Immunohistochemistry | Prognosis | Age Factors | United States | Humans | Middle Aged | Male | Bile Duct Diseases - chemically induced | Bile Duct Diseases - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Incidence | Statistics, Nonparametric | Aged, 80 and over | Adult | Female | Retrospective Studies | Dietary Supplements - adverse effects | Chemical and Drug Induced Liver Injury - pathology | Pharmaceutical Preparations - administration & dosage | Databases, Factual | Bile Ducts - drug effects | Risk Assessment | Chemical and Drug Induced Liver Injury - epidemiology | Drug-Related Side Effects and Adverse Reactions - etiology | Chi-Square Distribution | Drug-Related Side Effects and Adverse Reactions - epidemiology | Sex Factors | Aged | Biopsy, Needle | Bile Duct Diseases - pathology | Bile Ducts - pathology | Cohort Studies | Liver | Rodents | Dietary supplements | Bile
Journal Article
17.
Full Text
Poor Performance Status Is Associated With Increased Mortality in Patients With Cirrhosis
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 8, pp. 1189 - 1195.e1
Background & Aims Functional status (a patient’s ability to perform activities that meet basic needs, fulfill usual roles, and maintain health and well-being)...
Gastroenterology and Hepatology | Death | UNOS | Liver Disease | Survival | Waitlist | LIVER-TRANSPLANTATION | PROGNOSTIC-FACTORS | FRAILTY | RELIABILITY | PREVALENCE | FUNCTIONAL STATUS | TRENDS | PREDICTORS | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | VALIDITY | Biostatistics | Liver Cirrhosis - complications | United States | Humans | Middle Aged | Liver Cirrhosis - mortality | Male | Young Adult | Karnofsky Performance Status | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Medical colleges | Liver cirrhosis | Patient outcomes | Mortality | Medical research | Analysis | Liver | Medicine, Experimental | Transplantation of organs, tissues, etc | waitlist | death | liver disease | survival
Gastroenterology and Hepatology | Death | UNOS | Liver Disease | Survival | Waitlist | LIVER-TRANSPLANTATION | PROGNOSTIC-FACTORS | FRAILTY | RELIABILITY | PREVALENCE | FUNCTIONAL STATUS | TRENDS | PREDICTORS | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | VALIDITY | Biostatistics | Liver Cirrhosis - complications | United States | Humans | Middle Aged | Liver Cirrhosis - mortality | Male | Young Adult | Karnofsky Performance Status | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Medical colleges | Liver cirrhosis | Patient outcomes | Mortality | Medical research | Analysis | Liver | Medicine, Experimental | Transplantation of organs, tissues, etc | waitlist | death | liver disease | survival
Journal Article
Seminars in Liver Disease, ISSN 0272-8087, 05/2014, Volume 34, Issue 2, pp. 240 - 245
Abstract Drug-induced nodular regenerative hyperplasia is an uncommon injury with unique pathophysiology, clinical, and diagnostic considerations. This injury...
Diagnostic Problems in Hepatology | drug-induced liver injury | nodular regenerative hyperplasia | INFLAMMATORY-BOWEL-DISEASE | THERAPY | GASTROENTEROLOGY & HEPATOLOGY | INDUCED LIVER-INJURY | PORTAL-HYPERTENSION | CHEMOTHERAPY | LESIONS | FEATURES | Ascites - etiology | Liver Regeneration | Hypertension, Portal - etiology | Gastrointestinal Hemorrhage - etiology | Focal Nodular Hyperplasia - therapy | Humans | Focal Nodular Hyperplasia - diagnosis | Esophageal and Gastric Varices - etiology | Focal Nodular Hyperplasia - chemically induced | Withholding Treatment | Focal Nodular Hyperplasia - complications
Diagnostic Problems in Hepatology | drug-induced liver injury | nodular regenerative hyperplasia | INFLAMMATORY-BOWEL-DISEASE | THERAPY | GASTROENTEROLOGY & HEPATOLOGY | INDUCED LIVER-INJURY | PORTAL-HYPERTENSION | CHEMOTHERAPY | LESIONS | FEATURES | Ascites - etiology | Liver Regeneration | Hypertension, Portal - etiology | Gastrointestinal Hemorrhage - etiology | Focal Nodular Hyperplasia - therapy | Humans | Focal Nodular Hyperplasia - diagnosis | Esophageal and Gastric Varices - etiology | Focal Nodular Hyperplasia - chemically induced | Withholding Treatment | Focal Nodular Hyperplasia - complications
Journal Article
Surgical Endoscopy and Other Interventional Techniques, ISSN 0930-2794, 2018, Volume 33, Issue 6, pp. 1837 - 1845
BackgroundEndoscopic injection of cyanoacrylate into gastric varices may be performed by EUS-guided fine needle injection (EUS-FNI) or direct endoscopic...
Cyanoacrylate | Variceal bleeding | Fine needle injection | Endoscopic ultrasound | Gastric varices | SURGERY | N-BUTYL-2-CYANOACRYLATE INJECTION | HEMORRHAGE | SPLENIC VEIN-THROMBOSIS | CLASSIFICATION | THERAPY | FUNDAL VARICES | COIL EMBOLIZATION | GLUE | HISTOACRYL INJECTION | TERM FOLLOW-UP | Medicine, Experimental | Medical research | Nitriles | Endoscopy
Cyanoacrylate | Variceal bleeding | Fine needle injection | Endoscopic ultrasound | Gastric varices | SURGERY | N-BUTYL-2-CYANOACRYLATE INJECTION | HEMORRHAGE | SPLENIC VEIN-THROMBOSIS | CLASSIFICATION | THERAPY | FUNDAL VARICES | COIL EMBOLIZATION | GLUE | HISTOACRYL INJECTION | TERM FOLLOW-UP | Medicine, Experimental | Medical research | Nitriles | Endoscopy
Journal Article
Seminars in Diagnostic Pathology, ISSN 0740-2570, 03/2017, Volume 34, Issue 2, pp. 153 - 159
Hepatocellular carcinoma is a leading cancer worldwide. Its incidence is increasing, and is closely related to advanced liver disease. Cirrhosis represents the...
Cirrhosis | Screening | Resection | Treatment | Locoregional therapy | Barcelona Clinic Liver Cancer system | Diagnosis | Liver transplantation | UNITED-STATES | NODE-METASTASIS | LIVER-TRANSPLANTATION | RISK-FACTORS | EXTRAHEPATIC METASTASES | PROGNOSTIC-FACTORS | CHRONIC HEPATITIS-C | PATHOLOGY | SERUM ALPHA-FETOPROTEIN | DYSPLASTIC NODULES | 7 STAGING SYSTEMS | MEDICAL LABORATORY TECHNOLOGY | Liver Neoplasms - epidemiology | Carcinoma, Hepatocellular - epidemiology | Liver Neoplasms - diagnosis | Carcinoma, Hepatocellular - diagnosis | Humans | Risk Factors | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy
Cirrhosis | Screening | Resection | Treatment | Locoregional therapy | Barcelona Clinic Liver Cancer system | Diagnosis | Liver transplantation | UNITED-STATES | NODE-METASTASIS | LIVER-TRANSPLANTATION | RISK-FACTORS | EXTRAHEPATIC METASTASES | PROGNOSTIC-FACTORS | CHRONIC HEPATITIS-C | PATHOLOGY | SERUM ALPHA-FETOPROTEIN | DYSPLASTIC NODULES | 7 STAGING SYSTEMS | MEDICAL LABORATORY TECHNOLOGY | Liver Neoplasms - epidemiology | Carcinoma, Hepatocellular - epidemiology | Liver Neoplasms - diagnosis | Carcinoma, Hepatocellular - diagnosis | Humans | Risk Factors | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.